Verdad Advisers’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-935
Closed -$312K 132
2024
Q1
$312K Sell
935
-915
-49% -$280K 0.34% 106
2023
Q4
$501K Sell
1,850
-1,350
-42% -$334K 1.02% 34
2023
Q3
$787K Sell
3,200
-3,120
-49% -$854K 1.2% 20
2023
Q2
$1.92M Sell
6,320
-1,480
-19% -$411K 3% 9
2023
Q1
$2.06M Buy
+7,800
New +$1.98M 4.14% 4
2022
Q2
Sell
-14,000
Closed -$3.51M 36
2022
Q1
$3.51M Buy
+14,000
New +$3.52M 2.87% 16

Other funds holding HCA

Verdad Advisers's HCA Position: Q2 2024 in Review

Verdad Advisers sold out of HCA Healthcare (HCA) in Q2 2024, closing a stake of 935 shares — an estimated $312K sold.

Verdad Advisers first reported a position in HCA in Q1 2022 and held it in 6 quarters. The position peaked at $3.51M in Q1 2022. 1,155 funds tracked by Wall St. Rank hold HCA as of Q2 2024.

  • Verdad Advisers reported no remaining HCA Healthcare position as of Q2 2024 after selling out during the quarter.
  • Verdad Advisers sold 935 HCA Healthcare shares in Q2 2024, an estimated $312K.
  • Verdad Advisers first reported a position in HCA Healthcare in Q1 2022 and held it in 6 quarters.
  • Verdad Advisers's HCA Healthcare position peaked at $3.51M in Q1 2022.
  • 1,155 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2024.

Based on Verdad Advisers's 13F filing for Q2 2024, filed 6 Aug 2024.